In short. Cicatricial alopecia destroys the follicle permanently. How it is recognised, why biopsy is urgent, and what treatment can still achieve.

Key points

  • In scarring alopecia the aim of treatment is to stop the process, not to regrow hair in the affected area.
  • Success looks like stable disease: no new symptoms, no new bald patches, no further loss of follicular openings.
  • Hair lost before treatment started is lost permanently.

Scarring alopecia, also called cicatricial alopecia, is the one group of hair loss in which delay causes permanent harm. Inflammation destroys the follicle and replaces it with scar tissue. Once a follicle is gone it does not come back, and no treatment currently available can restore it. Everything about managing this condition is therefore organised around recognising it early and stopping the inflammation before more follicles are lost.

How it is recognised

The clinical clues differ from pattern hair loss. The scalp itself looks abnormal: redness around the follicular openings, scaling or flaking at the base of hairs, loss of the tiny openings that hairs emerge from, and a smooth, shiny, pale area where follicles have already gone. The person may notice itching, burning or tenderness, which is unusual in pattern hair loss. Loss may be patchy, may follow a band along the frontal hairline, or may be centred on the crown. Trichoscopy shows absent follicular openings, perifollicular scale and redness, and hair shafts that have disappeared from an area while the surrounding scalp looks inflamed.

The main types

Several distinct conditions cause it. Lichen planopilaris is an inflammatory condition that produces band-like loss with perifollicular scaling. Frontal fibrosing alopecia is a related pattern that recedes the frontal hairline and often affects the eyebrows as well. Discoid lupus of the scalp produces inflamed, scaly plaques that scar. Central centrifugal cicatricial alopecia begins on the crown and is associated with certain styling practices. Folliculitis decalvans produces pus-filled bumps and tufted hairs. They differ in cause and in treatment, and separating them is what the biopsy is for.

Why biopsy should not wait

A scalp biopsy taken from an area of active disease, examined for inflammation and for the pattern of scarring, is what distinguishes these conditions from each other and from non-scarring hair loss. Biopsy is most informative in active, untreated disease, which is precisely why a course of treatment started before the diagnosis can obscure the answer. Where the picture is unclear, a second sample is often taken for direct immunofluorescence.

The one message worth remembering

In scarring alopecia the aim of treatment is to stop the process, not to regrow hair in the affected area. Success looks like stable disease: no new symptoms, no new bald patches, no further loss of follicular openings. Hair lost before treatment started is lost permanently.

Treatment is anti-inflammatory and depends on the type: topical and injected corticosteroids, topical calcineurin inhibitors, and systemic agents including antimalarials, tetracycline-class antibiotics, and immunosuppressants when the disease is active or extensive. Response is judged over months, and long-term maintenance is usual.

Do not wait to seek care if

  • The scalp is itchy, burning, painful, scaly or red in an area of hair loss.
  • An area of scalp has become smooth, shiny or pale, or the follicular openings have vanished.
  • Eyebrows or eyelashes are thinning alongside scalp hair loss.

Related reading

Frequently asked questions

Can hair grow back in scarring alopecia?

No. Once a follicle is destroyed and replaced by scar tissue it does not come back, and no treatment currently available can restore it. Hair lost before treatment started is lost permanently.

Why is biopsy urgent in scarring alopecia?

Because the aim of treatment is to stop the process, not to regrow hair, and delay causes permanent harm. Biopsy is most informative in active, untreated disease, which is why a course of treatment started before the diagnosis can obscure the answer.

What does successful treatment look like here?

Stable disease: no new symptoms, no new bald patches, and no further loss of follicular openings. Anti-inflammatory treatment depends on the type, response is judged over months, and long-term maintenance is usual.

Risks & Limitations

  • Most hair loss is progressive and managed rather than reversed; treatment holds the line more often than it restores it.
  • Treatment takes 6–12 months before a response can be judged fairly, and must usually be continued indefinitely to keep the result.
  • Stopping treatment commonly means losing the hair that was regained, usually within months.
  • Some oral agents cause sexual, mood and metabolic side effects, and several require blood monitoring, blood-pressure monitoring, or pregnancy prevention.
  • Hair transplantation moves existing hair; it does not create new hair and does not stop the underlying process.
  • Scarring alopecia destroys the follicle permanently, so hair lost before treatment begins cannot be recovered.
  • No treatment works for everyone, and response cannot be predicted with certainty.

When to Seek Care

  • Sudden patchy hair loss, especially with scalp redness, scaling, itching or pain.
  • Hair loss with fever, joint pain, mouth ulcers, or a rash elsewhere on the body.
  • Scarring changes: an area of scalp that has become smooth, shiny or pale, with loss of the follicular openings.
  • Eyebrow or eyelash loss, which suggests a more extensive or systemic process.
  • Hair loss with fatigue, palpitations, weight change, or heavy or irregular periods — a systemic cause needs excluding.

References & Further Reading

  • American Academy of Dermatology (AAD) — public and clinical guidance on hair and scalp disorders
  • Chinese Medical Association, Dermatology Branch — clinical guidance
  • Cochrane Library — systematic reviews in dermatology
  • World Health Organization (WHO) — general health and nutrition resources

Medically reviewed by Yongbo Jia, MD (贾勇波), Deputy Director & Head of Dermatology. Last reviewed: 18 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.